Severity of COVID among type 2 diabetes patients
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: E118- Type 2 diabetes mellitus with unspecified complications
- Registration Number
- CTRI/2020/12/029454
- Lead Sponsor
- India Diabetes Research Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
>18 yrs male or female
COVID-19 positive
Exclusion Criteria
COVID 19 Negative
New-onset Diabetes with covid-19 infection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify the disease severity and outcome among people with and without diabetes hospitalized for COVID 19 virus infectionTimepoint: 14 days
- Secondary Outcome Measures
Name Time Method â?¢No. of patients who developed complications during the disease period (retinopathy, nephropathy, neuropathy, ischemic heart disease, cerebrovascular disease, peripheral artery disease, diabetic foot ulcer, hypertension, dyslipidemia)Timepoint: 14 days;Length of hospital stayTimepoint: 14 days;No. of patients recovered and dischargedTimepoint: 14 days;Number of deathTimepoint: 14 days;Number of patients who had respiratory complicationTimepoint: 14 days;Number of patients who had tracheal intubationTimepoint: 14 days;Number of patients who were in ICUTimepoint: 14 days;Pattern of treatment for coexisting diabetes, hypertension, dyslipidemia and coronary artery diseaseTimepoint: 14 days